Similarly, DNMT3a downregulation in breast tumors (n = 34) associates (p = 0.016237) with a poor disease-specific survival (HR[95% CI] = 0.33[0.07–1.54]) (Fig. 1E). The gene discussed is DNMT3A; the disease is breast neoplasm.